SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported): July 17, 2003
CLOSURE MEDICAL CORPORATION
(Exact Name of Registrant Specified in Charter)
| Delaware | 0-28748 | 56-1959623 | ||
(State or Other Jurisdiction of Incorporation) | (Commission File Number) | (I.R.S. Employer Identification No.) |
5250 Greens Dairy Road Raleigh, North Carolina | 27616 | |
| (Address of Principal Executive Offices) | (Zip Code) |
Registrant’s telephone number, including area code: (919) 876-7800
Not Applicable
(Former Name or Former Address, if Changed Since Last Report)
| Item 7. | Financial Statements, Pro Forma Financial Information and Exhibits. |
| (c) | Exhibits. |
| 99.1 | Press Release, dated July 17, 2003, issued by Closure Medical Corporation. |
| Item 9. | Regulation FD Disclosure. |
On July 17, 2003, Closure Medical Corporation disseminated a press release announcing its second quarter 2003 financial results.
Use of Non-GAAP Financial Information
To supplement its financial statements presented in accordance with GAAP, the Registrant uses the non-GAAP financial measure of Adjusted Net Income to enhance the user’s overall understanding of the Registrant’s current financial performance. Specifically, the Registrant believes that the presentation of Adjusted Net Income for prior periods provides useful information to both management and investors by allowing a meaningful comparison of the Registrant’s current operating results (which are fully-tax effected at 36 percent) to the operating results of prior periods (which were tax effected at less than two percent). The presentation of this additional information is not meant to be considered in isolation or as a substitute for results prepared in accordance with accounting principles generally accepted in the United States.
The information set forth under this “Item 9. Regulation FD Disclosure” is furnished under “Item 12. Results of Operations and Financial Condition” in accordance with SEC Release No. 33-8216. Such information (including the exhibit) shall not be deemed to be “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, nor shall it be incorporated by reference in any filing made by the Registrant pursuant to the Securities Act of 1933, as amended, other than to the extent that such filing incorporates by reference any or all of such information by express reference thereto.
-2-
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
CLOSURE MEDICAL CORPORATION (Registrant) | ||
By | /s/ BENNY WARD | |
Benny Ward Vice President of Finance and Chief Financial Officer | ||
Dated: July 17, 2003
-3-
Exhibit Index
| Exhibit | ||
| 99.1 | Press Release, dated July 17, 2003, issued by Closure Medical Corporation. | |
